Position in STE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$635,079
+$400,682 QoQ
Shares Held
3,016
+184.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#426
of 822 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STE Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $34,102,577 across 41 Medical Devices names. STE ranks #23 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
68,541 | $5,361,962 | |
| 2 | NPCE |
NeuroPace Inc
|
115,535 | $1,835,851 | |
| 3 | QTRX |
Quanterix Corp
|
410,252 | $1,772,288 | |
| 4 | PODD |
Insulet Corp
|
11,310 | $1,721,947 | |
| 5 | INFU |
InfuSystem Holdings, Inc
|
160,439 | $1,548,236 | |
| 6 | VMD |
Viemed Healthcare, Inc.
|
127,591 | $1,454,537 | |
| 7 | BSX |
Boston Scientific Corp
|
32,095 | $1,369,814 | |
| 8 | DXCM |
Dexcom Inc
|
19,820 | $1,334,877 |
All Filings in STE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $635,079 | 3,016 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $234,397 | 1,060 | Shares | Sole | 2026-05-08 | |
| 2025-09-30 | $529,521 | 2,140 | Shares | Sole | 2025-11-07 | |
| 2023-03-31 | $201,800 | 1,055 | Shares | Sole | 2023-05-12 | |
| 2021-09-30 | $231,040 | 1,131 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $449,108 | 2,549 | Shares | Sole | 2020-11-06 | |
| 2020-03-31 | $352,864 | 2,521 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||